Product NDC: | 65862-102 |
Proprietary Name: | Amlodipine Besylate |
Non Proprietary Name: | Amlodipine Besylate |
Active Ingredient(s): | 5 mg/1 & nbsp; Amlodipine Besylate |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 65862-102 |
Labeler Name: | Aurobindo Pharma Limited |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA078021 |
Marketing Category: | ANDA |
Start Marketing Date: | 20070717 |
Package NDC: | 65862-102-90 |
Package Description: | 90 TABLET in 1 BOTTLE (65862-102-90) |
NDC Code | 65862-102-90 |
Proprietary Name | Amlodipine Besylate |
Package Description | 90 TABLET in 1 BOTTLE (65862-102-90) |
Product NDC | 65862-102 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Amlodipine Besylate |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20070717 |
Marketing Category Name | ANDA |
Labeler Name | Aurobindo Pharma Limited |
Substance Name | AMLODIPINE BESYLATE |
Strength Number | 5 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [Chemical/Ingredient] |